Transgene and Tasly Biopharmaceuticals conclude strategic agreements for the rights of TG6002 and TG1050 in Greater China

, ,

By Lucie Larguier|2019-06-03T19:45:46+02:00July 10th, 2018|Press release, TG1050, TG6002|Comments Off